Rates of inappropriate antiretroviral prescription among injection drug users

Harm Reduction Journal

Volumn 4, Issue , 2007, Pages

  Wood, Evan ^a,b   Hogg, Robert S ^a,c   Kerr, Thomas ^a,b   Bonner, Simon ^a   Strathdee, Steffanie A ^d   Palepu, Anita ^a,b   Montaner, Julio S G ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c SIMON FRASER UNIVERSITY   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ADULT; ARTICLE; CANADA; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; PROSPECTIVE STUDY; VIRUS LOAD;

EID: 33846704201     PISSN: None     EISSN: 14777517     Source Type: Journal    
DOI: 10.1186/1477-7517-4-2     Document Type: Article

References (16)

1. Palella FJ Jr Delaney KM Moorman AC Loveless MO Fuhrer J Satten GA Aschman DJ Holmberg SD HIV Outpatient Study Investigators Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection N Engl J Med 1998 338 853-860 10.1056/ NEJM199803263381301 9516219
2. Hogg RS Heath KV Yip B Craib KJ O'Shaughnessy MV Schechter MT Montaner JS Improved survival among HIV-infected individuals following initiation of antiretroviral therapy JAMA 1998 279 450-454 10.1001/jama.279.6.450 9466638
3. Ledergerber B Egger M Opravil M Telenti A Hirschel B Battegay M Vernazza P Sudre P Flepp M Furrer H Francioli P Weber R for the Swiss HIV Cohort Study Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: A prospective cohort study Lancet 1999 353 863-868 10.1016/S0140-6736(99)01122-8 10093977
4. Hogg RS Yip B Chan KJ Wood E Craib KJ O'Shaughnessy MV Montaner JS Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy JAMA 2001 286 2568-2577 10.1001/ jama.286.20.2568 11722271
5. Ickovics JR Meade CS Adherence to HAART among patients with HIV: breakthroughs and barriers AIDS Care 2002 14 309-318 10.1080/ 09540120220123685 12042076
6. Strathdee SA Palepu A Cornelisse PG Yip B O'Shaughnessy MV Montaner JS Schechter MT Hogg RS Barriers to use of free antiretroviral therapy in injection drug users JAMA 1998 280 547-549 10.1001/jama.280.6.547 9707146
7. Wood E Montaner JS Bangsberg D Tyndall MW Strathdee SA O'Shaughnessy MV Hogg RS Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world AIDS 2003 17 2419-2427 10.1097/00002030-200311210-00003 14600512
8. Wood E Montaner JS Schechter MT Tyndall MW O'Shaughnessy MV Hogg RS Prevalence and correlates of untreated HIV-1 infection among persons who have died in the era of modern antiretroviral therapy J Infect Dis 2003 188 1164-1170 10.1086/378703 14551887
9. Wood E Montaner JS Chan K Tyndall MW Schechter MT Bangsberg D O'Shaughnessy MV Hogg RS Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996 AIDS 2002 16 2065-2072 10.1097/ 00002030-200210180-00012 12370506
10. Wood E Hogg RS Bonner S Kerr T Li K Palepu A Guillemi S Schechter MT Montaner JSG Staging for antiretroviral therapy among HIV-infected drug users JAMA 2004 292 1175-1177 10.1001/jama.292.10.1175-b 15353528
11. + cell count is 0.200 to 0.350 × 109 cells/L Ann Intern Med 2003 139 810-816 14623618
12. Hogg RS Yip B Kully C Craib KJ O'Shaughnessy MV Schechter MT Montaner JS Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens CMAJ 1999 160 659-665 1230111 10102000
13. Wood E Montaner JS Yip B Tyndall MW Schechter MT O'Shaughnessy MV Hogg RS Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users CMAJ 2003 169 656-661 202281 14517122
14. Wainberg MA Friedland G Public health implications of antiretroviral therapy and HIV drug resistance JAMA 1998 279 1977-1983 10.1001/ jama.279.24.1977 9643862
15. Bangsberg D Tulsky JP Hecht FM Moss AR Protease inhibitors in the homeless JAMA 1997 278 63-65 10.1001/jama.278.1.63 9207341
16. Yeni PG Hammer SM Carpenter CC Cooper DA Fischl MA Gatell JM Gazzard BG Hirsch MS Jacobsen DM Katzenstein DA Montaner JS Richman DD Saag MS Schechter M Schooley RT Thompson MA Vella S Volberding PA Antiretroviral treatment for adult HIV infection in 2002: Updated recommendations of the International AIDS Society-USA Panel JAMA 2002 288 222-2]35 10.1001/ jama.288.2.222 12095387